MAPK1 and hypoalphalipoproteinemia, primary, 1: In vivo experiments confirmed the therapeutic effect of FHD on NS and revealed that the underlying mechanisms are closely associated with PI3K-Akt pathway, PTGS2, MAPK1, and IL-6.